Gemini Therapeutics Inc
NASDAQ:GMTX
Cash Flow Statement
Cash Flow Statement
Gemini Therapeutics Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Operating Cash Flow | ||||
Net Income |
(1)
|
(72)
|
(47)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
|
Other Non-Cash Items |
(0)
|
10
|
2
|
|
Cash Interest Paid |
0
|
0
|
0
|
|
Change in Working Capital |
0
|
2
|
2
|
|
Cash from Operating Activities |
(0)
N/A
|
(60)
-14 237%
|
(42)
+29%
|
|
Investing Cash Flow | ||||
Capital Expenditures |
0
|
(0)
|
(0)
|
|
Other Items |
(121)
|
0
|
0
|
|
Cash from Investing Activities |
(121)
N/A
|
0
N/A
|
(0)
N/A
|
|
Financing Cash Flow | ||||
Net Issuance of Common Stock |
125
|
0
|
54
|
|
Net Issuance of Debt |
0
|
(5)
|
0
|
|
Other |
(3)
|
196
|
95
|
|
Cash from Financing Activities |
122
N/A
|
191
+56%
|
149
-22%
|
|
Change in Cash | ||||
Net Change in Cash |
1
N/A
|
132
+10 801%
|
107
-19%
|
|
Free Cash Flow | ||||
Free Cash Flow |
(0)
N/A
|
(60)
-14 254%
|
(42)
+29%
|